Hyperhomocysteinemia and vitamin score: Correlations with silent brain ischemic lesions and brain atrophy

Dementia and Geriatric Cognitive Disorders

Volumn 16, Issue 1, 2003, Pages 39-45

  Polyak, Zeev ^a   Stern, Felicia ^b   Berner, Yitshal N ^c   Sela, Ben Ami ^d   Gomori, John M ^b   Isayev, Marina ^a   Doolman, Ram ^d   Levy, Shmuel ^a   Dror, Yosef ^b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Brain atrophy; Brain ischemia; Folic acid; Homocysteine; Vitamin B12; Vitamin B6

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE;

AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BIOLOGICAL MONITORING; BRAIN ATROPHY; CALCULATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GERIATRIC PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; MEDICAL ASSESSMENT; OUTPATIENT; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ATROPHY; BRAIN; BRAIN ISCHEMIA; COGNITION DISORDERS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; VITAMIN B 12; VITAMIN B 6; VITAMINS;

EID: 0344511607     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069992     Document Type: Article

References (43)

1. Lopez AD, Murray CC: The global burden of disease, 1990-2020. Nat Med 1998;4:1241-1243.
2. Vermeer SE, Van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, Breteler MMB: Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol 2002;51:285-289.
3. Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR: Lacunar infarcts defined by magnetic resonance imaging of 3,660 elderly people. The Cardiovascular Health Study. Arch Neurol 1998;55:1217-1225.
4. Anderton BH: Changes in the ageing brain in health and disease. Philos Trans R Soc Lond B Biol Sci 1997;352:1781-1792.
5. Sehl ME, Yates FE: Kinetics of human aging. 1. Rates of senescence between ages 30 and 70 years in healthy people. J Gerontol A Biol Sci Med Sci 2001;56:B198-B208.
6. Robinson K (ed): Homocysteine and Vascular Disease. Dordrecht, Kluwer, 2000.
7. Carmel R, Jacobsen DW (eds): Homocysteine in Health and Disease. Cambridge, Cambridge University Press, 2001.
8. Perry IJ: Homocysteine as a risk factor for cerebrovascular disease and stroke; in Robinson K (ed): Homocysteine and Vascular Disease. Dordrecht, Kluwer, 2000, pp 151-172.
9. Coen DA, Stehouwer MP, Weijenberg MVDB, Cornelis J, Edith JM, Feskens DK: Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men, a 10-year follow-up. Arterioscler Thromb Vasc Biol 1998;18:1895-1901.
10. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH: Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-291.
11. Duell PB, Malinow AR: Homocysteine as a risk factor for coronary artery disease; in Robinson K (ed): Homocysteine and Vascular Disease. Dordrecht, Kluwer, 2000, pp 173-202.
12. Ueland PM, Refsum H, Beresford SAA, Vollset SE: The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000;72:324-332.
13. Matsui T, Arai H, Yuzuriha T, Yao H, Miura M, Hashimoto S, Higuchi S, Matsushita S, Morikawa M, Kato A, Sasaki H: Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke 2001;32:1116-1119.
14. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PWF, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
15. Central Bureau of Statistics, State of Israel: Statistical Abstract of Israel, 2001.
16. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM: Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin Chem 1993;39:263-271.
17. 6-vitamers in serum and whole blood. Int J Vitam Nutr Res 1987;57:273-278.
18. Turner-Stokes L, Nyein K, Turner-Stokes T, Gatehouse C: The UK FIM + FAM: Development and evaluation. Clin Rehabil 1999;13:277-287.
19. Rubenstein LZ: Assessment instruments; in Abrams WB, Berkow R (eds): The Merck Manual of Geriatrics. Rathway, Merck, 1990, pp 1189-1200.
20. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
21. Fidanza F: Nutritional Status Assessment. London, Chapman © Hall, 1991.
22. Loeb C, Gandolfo C, Croce R, Conti M: Dementia associated with lacunar infarction. Stroke 1992;23:1225-1229.
23. Maxwell CJ, Hogan DB, Ebly EM: Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons. Dement Geriatr Cogn Disord 2002;13:225-234.
24. Fassbender K, Mielke O, Bertsch T, Nafe B, Froschen S, Hennerici M: Homocysteine in cerebral macroangiography and microangiopathy. Lancet 1999;353:1586-1587.
25. Lehmann M, Gottfries CG, Regland B: Identification of cognitive impairment in the elderly: Homocysteine is an early marker. Dement Geriatr Cogn Disord 1999;10:12-20.
26. 12, Pantothenic Acid, Biotin and Choline. Washington, National Academy Press, 1998, pp 518-519.
27. Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR: Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: Findings from the Nun Study. Am J Clin Nutr 2000;71:993-998.
28. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449-1455.
29. Weir DG, Molloy AM: Microvascular disease and dementia in the elderly: Are they related to hyperhomocysteinemia? Am J Clin Nutr 2000;71:859-860.
30. Rosenberg IH: B vitamins, homocysteine, and neurocognitive function. Nutr Rev 2001;59:S69-S74.
31. Schmidt R, Fazekas F, Hayn M, Schmidt H, Kapeller P, Roob G, Offenbacher H, Schumacher M, Eber B, Weinrauch V, Kostner GM, Esterbauer H: Risk factors for microangiopathy-related cerebral damage in the Austrian Stroke Prevention Study. J Neurol Sci 1997;152:15-21.
32. Berner YN, Stern F, Polyak Z, Dror Y: Dietary intake analysis in institutionalized elderly, a focus on nutrient density. J Nutr Health Aging 2002;6:237-242.
33. Hankey GJ: Is homocysteine a causal and treatable risk factor for vascular diseases of the brain (cognitive impairment and stroke)? Ann Neurol 2002;51:279-281.
34. Schnyder G, Roffi M, Pin I, Flammer Y, Lange H, Eberli FR, Meier B, Turi ZG, Hess OM: Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001;345:1593-1600.
35. Peterson JC, Spence JD: Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia. Lancet 1998;351:263.
36. 12 and folate tissue deficiency markers amongst elderly Swedes - a population-based study. J Intern Med 2001;249:423-432.
37. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-1050.
38. Eikelboom JW, Lonn E, Genest JJr, Hankey G, Yusuf S: Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence. Ann Intern Med 1999;131:363-375.
39. Koch HG, Goebeler M, Marquardt T, Roth J, Harms E: The redox status of aminothiols as a clue to homocysteine-induced vascular damage? Eur J Pediatr 1998;157(suppl 2):S102-S106.
40. McKinley MC: Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: An independent risk factor for vascular disease. Proc Nutr Soc 2000;59:221-237.
41. Morrow L: Homocysteine: More questions than answers. Nutrition 2000;16:780-781.
42. Dror Y, Stern F, Berner YN, Kaufmann NA, Berry E, Maaravi Y, Altman H, Cohen A, Leventhal A, Nitzan-Kaluski D: Recommended micronutrient supplementation for institutionalized elderly. J Nutr Health Aging 2002;6:295-300.
43. Heseker H: Micronutrients supplementation recommendations for the elderly suggested by a public committee. J Nutr Health Aging 2002;6:294 (editorial).